Comparison of rise in vitamin D levels after oral dose of vitamin D in obese and non-obese childre
- Conditions
- Health Condition 1: E559- Vitamin D deficiency, unspecified
- Registration Number
- CTRI/2019/04/018640
- Lead Sponsor
- Dr Medha Mittal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 44
Cases- Obese Indian children (Obesity as defined by BMI more than 27 th adult equivalent
of Indian Academy of Pediatrics BMI charts) of age group 5 to 12 years presenting to Out-patient clinic
and pediatric endocrinology clinic at Chacha Nehru Bal Chikitsalaya, Delhi will
be screened and included in the study if their vitamin D levels are less than 20
ng/ml.
Controls- Apparently healthy children, not overweight or obese, of age group 5-
12 years presenting to pediatric OPD for minor complaints (like cough, coryza
for less than 5 days) will be screened for vitamin D deficiency and included in
the study if their vitamin D levels are less than 20 ng/ml.
1. Children with confirmed or suspected malabsorption, renal or hepatic
disorders.
2. Children who have received vitamin D in therapeutic doses in last 6 months.
3. Children on psoralen and ultraviolet A therapy (PUVA) for some skin disorder.
4. Children who have received drugs that may interfere with vitamin D
metabolism like anticonvulsants, steroids, chemotherapy, antitubercular drugs,
H2 Blockers, and thiazide diuretics and those on any herbal or ayurvedic
medications.
5. Children with any known systemic illness or endocrine or metabolic disorder
known to be associated with obesity either before or during the course of study
or subjects with symptoms suggestive of hypothalamic obesity.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method